Dr. Scott Gettinger

Biography

Scott Gettinger, MD, is a medical oncologist specializing in lung cancer treatment research. He is known for his internationally recognized expertise in the field, particularly in the areas of immunotherapy and targeted therapy for non-small cell lung cancer. Dr. Gettinger leads clinical trials aimed at evaluating novel therapies for patients suffering from this type of lung cancer. His primary translational research interests focus on understanding the mechanisms of sensitivity and resistance to molecularly targeted therapies and immunotherapies. He is involved in various clinical trials and dedicates his efforts to provide the latest advances in treatment for patients with complicated cases that require multidisciplinary care. Dr. Gettinger emphasizes the importance of evolving treatments for lung cancer, noting that new therapies aimed at targeting specific tumors are continually being developed, ensuring that he has something to offer to those in need. His work is instrumental in the ongoing advancement of treatment strategies in oncology, particularly within thoracic oncology, where his expertise is particularly impactful.

Research Interests